METHOD OF IMMUNODEPENDANT COMPLICATIONS PREVENTION FOR CARDIOSURGERY PATIENTS IN POSTOPERATIVE PERIOD

FIELD: medicine; cardiology. ^ SUBSTANCE: invention can be applied for prevention of immunodependant complications for cardiosurgery patients in postoperative period. For this purpose 7-10 days before operation self-restricted bone marrow cells (BMC) are sampled. Mononuclear fraction BMC is marked o...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	GABRIEHLJAN NINA INDZAROVNA, NIKOL'SKAJA ALLA OLEGOVNA, ONISHCHENKO NINA ANDREEVNA, SHUMAKOV VALERIJ IVANOVICH, SUKHACHEV ANTON ALEKSANDROVICH, GUREEV SERGEJ VASIL'EVICH, SAVOST'JANOVA OL'GA ALEKSANDROVNA, TEMNOV ANDREJ ALEKSANDROVICH, VASIL'EV KIRILL NIKOLAEVICH
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine; cardiology. ^ SUBSTANCE: invention can be applied for prevention of immunodependant complications for cardiosurgery patients in postoperative period. For this purpose 7-10 days before operation self-restricted bone marrow cells (BMC) are sampled. Mononuclear fraction BMC is marked out in vitro. It is cultivated in gas medium within 7 to 10 days and introduced to patient during operation intramyocardially or intracoronary. ^ EFFECT: invention provides reparative regeneration of myocardium and reduction of infection-septic complications and organ dysfunctions. ^ 2 tbl, 4 dwg